Impact of New Vision Research
Through the Charleston Conference on Alzheimer’s Disease (CCAD), New Vision Research (NVR) has had a significant impact on the field of Alzheimer’s disease research. Two ways to observe and measure this impact is by the continued and proliferating collaboration between CCAD alumni, and the long-term effect receiving seed funding through the New Vision Investigator Award has on scientists’ ability to secure subsequent federal grant funding.
Impact Through Collaboration
During CCAD, scientists from all fields of AD research attend the conference, present their research proposals to all attendees, take advantage of networking opportunities, and are encouraged to collaborate with their research.
At traditional conferences, scientists are divided into their respective fields and only attend seminars in their one field. One of the greatest and most unique advantages of CCAD is the disruption of this tradition, whereby scientists from all fields attend, listen to and review research proposals of colleagues from all fields of research. Since 2013, scientists from the following fields have attended CCAD:
In the years since CCAD’s inception, the network of collaboration created by CCAD alumni has grown tremendously and demonstrates the success of the CCAD model in fostering innovative collaboration across different fields of AD research. These partnerships take different forms and some attendees have worked with ten or more fellow alumni. The following image displays all collaborations between alumni:
Impact Through Grant Funding
Traditionally, early-career scientists and those with more novel approaches to their research face considerable difficulty securing funding for their work. This is partly due to the higher-risk nature of their work, while both established scientists and those pursuing proven methods of study are considered less risky to fund. New Vision Research alters the current landscape of funding by intentionally connecting and supporting early-career researchers with innovative ideas through CCAD.
While NVR acknowledges the selection bias of the data below, by tracking the career trajectory of CCAD nominees, attendees and awardees over the past seven years, it is apparent that the opportunities afforded to the CCAD community serve as a significant boost to their ability to secure subsequent funding. This is a testament to the impact of cross-field collaboration and seed funding for early-career scientists and their affiliated institutions and organizations.
The New Vision Research model for CCAD is well established and can be replicated for other illnesses or areas of research. It is NVR’s goal to expand this model to help advance research in other diseases. Click below to learn more about sponsoring a conference.